Allarity Therapeutics, Inc. Other General Expense
Allarity Therapeutics, Inc. (ALLR) reported Other General Expense of $20.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherGeneralExpense · last filed 2023-11-14
- Allarity Therapeutics, Inc. other general expense for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. other general expense for the quarter ending 2023-06-30 was -$60.00K, a 400.00% decline year-over-year.
- Allarity Therapeutics, Inc. other general expense for the quarter ending 2023-03-31 was $80.00K, a 95.12% increase year-over-year.
- Allarity Therapeutics, Inc. other general expense for the quarter ending 2022-09-30 was $20.00K, a 96.53% decline year-over-year.
| Period end | Other General Expense 3 month | Other General Expense 6 month | Other General Expense 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$60.00K derived: sum of 2 quarters · filed 2023-11-14 | $20.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $20.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $80.00K 10-Q · filed 2023-05-11 | ||
| 2022-09-30 | $20.00K 10-Q · filed 2023-11-14 | $40.00K derived: sum of 2 quarters · filed 2023-11-14 | $664.00K 10-Q · filed 2023-11-14 |
| 2022-06-30 | $20.00K 10-Q · filed 2023-08-14 | $664.00K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $41.00K 10-Q · filed 2023-05-11 | ||
| 2021-09-30 | $577.00K 10-Q · filed 2022-11-14 | $1.01M derived: sum of 2 quarters · filed 2022-11-14 | $1.21M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $433.00K 10-Q · filed 2022-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |